{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:38Z","timestamp":1781927558508,"version":"3.54.5"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.2169\/internalmedicine.6203-25","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:13Z","timestamp":1763589973000},"page":"1704-1709","source":"Crossref","is-referenced-by-count":0,"title":["Serial Cerebral Blood Flow Changes in AMPAR Encephalitis Presenting with Left Hemiplegia and Nonfluent Aphasia"],"prefix":"10.2169","volume":"65","author":[{"given":"Taiki","family":"Matsubayashi","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Disaster Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Furuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Disaster Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Obayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Disaster Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. H\u00f6ftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84: 2403-2412, 2015.","DOI":"10.1212\/WNL.0000000000001682"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang TY, Cai MT, Zheng Y, et al. Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review. Front Immunol 12: 652820, 2021.","DOI":"10.3389\/fimmu.2021.652820"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fukumoto T, Miyamoto R, Fujita K, Murakami N, Matsui N, Izumi Y. Reversible mixed perfusion on <sup>123<\/sup>I-IMP SPECT in anti-AMPA receptor encephalitis: a case report. J Neurol Sci 421: 117306, 2021.","DOI":"10.1016\/j.jns.2020.117306"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Joubert B, Kerschen P, Zekeridou A, et al. Clinical spectrum of encephalitis associated with antibodies against the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol 72: 1163-1169, 2015.","DOI":"10.1001\/jamaneurol.2015.1715"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhang Z, Fan S, Ren H, Zhou L, Guan H. Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis. BMC Neurol 21: 490, 2021.","DOI":"10.1186\/s12883-021-02520-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65: 424-434, 2009.","DOI":"10.1002\/ana.21589"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 15: 1391-1419, 2015.","DOI":"10.1586\/14737175.2015.1115720"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fang Y, Pan D, Huang H. Recurrent anti-AMPA receptor limbic encephalitis: a case report and literature review. Front Neurol 12: 735983, 2021.","DOI":"10.3389\/fneur.2021.735983"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang K, Shi Y, Du Q, et al. Clinical review and prognostic analysis of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-associated encephalitis. Front Neurol 12: 665229, 2021.","DOI":"10.3389\/fneur.2021.665229"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang C, Kong F, Yu X, et al. Clinical characteristics and outcome in patients with anti-AMPAR2 encephalitis: a case series and literature review. Front Hum Neurosci 19: 1586005, 2025.","DOI":"10.3389\/fnhum.2025.1586005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wei YC, Liu CH, Lin JJ, et al. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol 261: 129-133, 2013.","DOI":"10.1016\/j.jneuroim.2013.05.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Spatola M, Stojanova V, Prior JO, Dalmau J, Rossetti AO. Serial brain <sup>18<\/sup>FDG-PET in anti-AMPA receptor limbic encephalitis. J Neuroimmunol 271: 53-55, 2014.","DOI":"10.1016\/j.jneuroim.2014.04.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS. Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol 266: 450-460, 2019.","DOI":"10.1007\/s00415-018-9153-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wei YC, Tseng JR, Wu CL, et al. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: case report and literature review. Brain Behav 10: e01540, 2020.","DOI":"10.1002\/brb3.1540"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Probasco JC, Solnes L, Nalluri A, et al. Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4: e352, 2017.","DOI":"10.1212\/NXI.0000000000000352"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ohta K, Seki M, Dalmau J, Shinohara Y. Perfusion <sup>123<\/sup>IMP-SPECT shows reversible abnormalities in GABA<sub>B<\/sub> receptor antibody associated encephalitis with normal MRI. Brain Behav 1: 70-72, 2011.","DOI":"10.1002\/brb3.14"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fisher RE, Patel NR, Lai EC, Schulz PE. Two different <sup>18<\/sup>F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 37: e213-e218, 2012.","DOI":"10.1097\/RLU.0b013e31824852c7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Leypoldt F, Buchert R, Kleiter I, et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 83: 681-686, 2012.","DOI":"10.1136\/jnnp-2011-301969"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Abboud H, Probasco JC, Irani S, et al.; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92: 757-768, 2021.","DOI":"10.1136\/jnnp-2020-325300"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6203-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:16Z","timestamp":1781926636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6203-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6203-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"6203-25"}}